The Cochrane Collaboration
Cochrane Reviews
Explore New + Updated Other languages
Full Text:  The Cochrane Library
search & browse | by topic | full list of all reviews | by country of author | by date range

by Topic (Review Group):

Browse by topic (Review Group) - For sub-topics (only reviews + protocols), click here


View stages (what is this?): all titles Titles protocol Protocols review Reviews

Action plans for chronic obstructive pulmonary disease
Updated
Acupuncture for chronic asthma
Acute and chronic therapies in the management of episodic viral wheeze of childhood (title stage)
Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children
Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma
Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children (title stage)
Adenotonsillectomy for obstructive sleep apnoea in children
Adjustable maintenance dosing of combination inhaled steroid and long-acting beta agonist for asthma (title stage)
Alexander technique for chronic asthma
Allergen immunotherapy for asthma
withdrawn
Almitrine for chronic obstructive pulmonary disease (protocol stage)
Ambulatory oxygen for chronic obstructive pulmonary disease
Anti-histamines for prolonged non-specific cough in children
Anti-IgE for chronic asthma in adults and children
Anti-inflammatory medications for obstructive sleep apnea syndrome in children (protocol stage)
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
Antibiotics for acute asthma
withdrawn
Antibiotics for chronic suppurative lung disease in children (protocol stage)
Antibiotics for prolonged moist cough in children
Anticholinergic agents for chronic asthma in adults
Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
Anticholinergic drugs for wheeze in children under the age of two years
Anticholinergic therapy for acute asthma in children (protocol stage)
Anticholinergic therapy for bronchiectasis
Anticholinergic therapy for chronic asthma in children over two years of age
Anticholinergics for prolonged non-specific cough in children
withdrawn
Anticoagulation therapy for pulmonary hypertension (protocol stage)
Updated
Azathioprine as an oral corticosteroid sparing agent for asthma
Updated
Azoles for allergic bronchopulmonary aspergillosis associated with asthma
Beclomethasone at different doses for chronic asthma
Beclomethasone for asthma in children: effects on linear growth
Beclomethasone versus budesonide for chronic asthma
Beclomethasone versus placebo for chronic asthma
Beta-2 agonists for exercise induced asthma (protocol stage)
withdrawn
Beta2-receptor polymorphism for improving long-term beta-agonist efficacy in asthma (protocol stage)
withdrawn
Breast feeding and development of childhood wheeze (protocol stage)
Breathing exercises for asthma
Bronchial thermoplasty for chronic asthma in adults (title stage)
Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis
Budesonide at different doses for chronic asthma
Budesonide versus placebo for chronic asthma in children and adults
Caffeine for asthma
withdrawn
Calcium channel blockers for pulmonary hypertension (protocol stage)
Calorie controlled diet for chronic asthma
Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease
Cardioselective beta-blockers for chronic obstructive pulmonary disease
Cardioselective beta-blockers for reversible airway disease
Chloroquine as a steroid sparing agent for asthma
Ciclesonide versus other inhaled steroids for chronic asthma in children and adults
Ciclesonide versus placebo for chronic asthma in adults and children
Clinical pathways for chronic cough in children
Colchicine as an oral corticosteroid sparing agent for asthma
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children
Combination formoterol and inhaled steroid as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children (protocol stage)
Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children (protocol stage)
Combination inhaled steroid and long-acting beta-agonist versus tiotropium for chronic obstructive pulmonary disease (title stage)
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma
Combined corticosteroid and long-acting beta-agonist in one inhaler for chronic asthma (protocol stage)
Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
withdrawn
Combined corticosteroid and short-acting bronchodilator in one inhaler for chronic obstructive pulmonary disease (protocol stage)
Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children
Combined inhaled beta-agonist and anticholinergic agents in the emergency management of adult asthmatic patients (protocol stage)
Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children
Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea
Continuous positive airways pressure for obstructive sleep apnoea in adults
Continuous versus intermittent beta-agonists for acute asthma
Corticosteroids for acute severe asthma in hospitalised patients
Corticosteroids for hospitalised children with acute asthma
Corticosteroids for idiopathic pulmonary fibrosis
Corticosteroids for preventing relapse following acute exacerbations of asthma
Corticosteroids for pulmonary sarcoidosis
Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults
withdrawn
Cow's milk protein avoidance and development of childhood wheeze in children with a family history of atopy
Culture-specific programs for children and adults from minority groups who have asthma
Cyclophosphamide for interstitial lung disease (protocol stage)
Cyclosporin as an oral corticosteroid sparing agent in stable asthma
Dapsone as an oral corticosteroid sparing agent for asthma
Dietary marine fatty acids (fish oil) for asthma in adults and children
Dietary salt reduction or exclusion for allergic asthma
Different corticosteroid dosing strategies at discharge for acute asthma (title stage)
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease (protocol stage)
Domiciliary oxygen for chronic obstructive pulmonary disease
Domiciliary oxygen for interstitial lung disease
Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease
Drug therapy for obstructive sleep apnoea in adults
Early emergency department treatment of acute asthma with systemic corticosteroids
Early use of inhaled corticosteroids in the emergency department treatment of acute asthma
Education interventions for adults who attend the emergency room for acute asthma
withdrawn
Educational interventions for asthma in adults (protocol stage)
Educational interventions for asthma in children
Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines for adults with obstructive sleep apnoea (title stage)
Endothelin receptor antagonists for pulmonary arterial hypertension
withdrawn
Exposure to nitrogen dioxide for assessing allergen responsiveness in asthma (protocol stage)
Family therapy for asthma in children
Feather versus non-feather bedding for asthma
withdrawn
Flunisolide for chronic asthma (protocol stage)
Updated
Fluticasone at different doses for chronic asthma in adults and children
Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children
Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children
Updated
Fluticasone versus placebo for chronic asthma in adults and children
New
Galactomannan detection for invasive aspergillosis in immunocompromized patients
Gastro-oesophageal reflux treatment for asthma in adults and children
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults
Gold as an oral corticosteroid sparing agent in stable asthma
Heliox for nonintubated acute asthma patients
Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
Herbal interventions for chronic asthma in adults and children
High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
Updated
Holding chambers versus nebulisers for inhaled steroids in chronic asthma
Home care by outreach nursing for chronic obstructive pulmonary disease
Homeopathy for chronic asthma
Honey and lozenges for children with non-specific cough (title stage)
Hospital at home for acute exacerbations of chronic obstructive pulmonary disease
House dust mite control measures for asthma
Humidification of inspired air in exercise-induced asthma (protocol stage)
Humidity control for chronic asthma
withdrawn
Hydrotherapy for asthma (protocol stage)
Immunomodulatory agents for idiopathic pulmonary fibrosis
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
Increased versus stable doses of inhaled steroids for exacerbations of chronic asthma in adults and children (title stage)
Indigenous healthcare worker involvement for Indigenous adults and children with asthma
Indoor air modification interventions for prolonged non-specific cough in children
Influenza vaccine for children and adults with bronchiectasis
Influenza vaccine for patients with chronic obstructive pulmonary disease
Inhaled and oral corticosteroids as maintenance and intermittent therapy for episodic viral wheeze in children
Inhaled beta2-agonists for asthma in mechanically ventilated patients
Inhaled beta2-agonists for non-specific chronic cough in children
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease
Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction
Inhaled corticosteroids for non-specific chronic cough in children
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Inhaled corticosteroids versus long acting beta-agonists for chronic obstructive pulmonary disease (protocol stage)
Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma
Updated
Inhaled cromones for prolonged non-specific cough in children
Inhaled hyperosmolar agents for bronchiectasis
withdrawn
Inhaled ipratropium bromide for stable chronic obstructive pulmonary disease (protocol stage)
Inhaled magnesium sulfate in the treatment of acute asthma
Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis (title stage)
Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment
Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
Updated
Inhaled sodium cromoglycate for asthma in children
Inhaled steroids for acute asthma following emergency department discharge
Inhaled steroids for bronchiectasis
Inhaled steroids for neonatal chronic lung disease
Inhaled versus oral steroids for adults with chronic asthma
Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease
Inspiratory muscle training for asthma
withdrawn
Inspiratory muscle training for chronic obstructive pulmonary disease (protocol stage)
Interventions for adherence to pulmonary rehabilitation for chronic obstructive pulmonary disease (protocol stage)
Interventions for educating children who have attended the emergency room for asthma
withdrawn
Interventions for improving asthma care in ethnic minorities (protocol stage)
Interventions for primary (intrinsic) tracheomalacia in children
Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema
Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis
Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
Intravenous beta2-agonists for acute asthma in the emergency department
withdrawn
Intravenous immunoglobulin as a corticosteroid sparing agent for chronic asthma (protocol stage)
Ionisers for chronic asthma
Updated
Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease
Updated
Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease
Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children
Leucotriene receptor antagonists in addition to usual care for acute asthma in adults and children (protocol stage)
Leukotriene receptor antagonist for prolonged non-specific cough in children
Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children (title stage)
Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis
Lifestyle modification for obstructive sleep apnoea
Limited (information only) patient education programs for adults with asthma
Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children
Updated
Long-acting beta2-agonists for bronchiectasis
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid
Long-acting beta2-agonists for chronic obstructive pulmonary disease: serious adverse events (protocol stage)
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease
Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma
Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in adults and children with chronic asthma
Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma
Lung volume reduction surgery for diffuse emphysema
Macrolides for chronic asthma
Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
Maintenance and reliever combination formoterol and budesonide versus fixed dose combination salmeterol and fluticasone plus short-acting beta-agonist for chronic asthma in adults and children (title stage)
Manual therapy for asthma
Updated
Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction
Methotrexate as an oral corticosteroid sparing agent for asthma in adults
Methylxanthines for exacerbations of chronic obstructive pulmonary disease
Methylxanthines for prolonged non-specific cough in children
Mometasone for asthma in adults and children (protocol stage)
Mono and multifaceted allergen reduction interventions for preventing asthma in children at high risk of developing asthma (protocol stage)
Monosodium glutamate avoidance for chronic asthma in adults and children (protocol stage)
Updated
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
Mucolytics for bronchiectasis
Updated
Nebulised morphine for severe interstitial lung disease
Nebulisers versus all hand-held inhalers to deliver bronchodilators in chronic obstructive pulmonary disease (protocol stage)
Nebulisers versus hand-held inhalers to deliver beta2-agonist bronchodilator drugs in non-acute asthma (protocol stage)
Nedocromil sodium for chronic asthma in children
Nedocromil sodium for preventing exercise-induced bronchoconstriction
Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction
Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease
Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease
Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma
Non-invasive ventilation during exercise training for people with chronic obstructive pulmonary disease (title stage)
withdrawn
Non-selective beta agonists versus beta2-agonists for acute asthma (protocol stage)
Updated
Nurse specialist care for bronchiectasis
Nutritional supplementation for stable chronic obstructive pulmonary disease
Options for self-management education for adults with asthma
Oral and systemic steroids at different doses for acute asthma in hospitalised children (protocol stage)
Oral appliances for obstructive sleep apnoea
Oral corticosteroids for stable chronic obstructive pulmonary disease
Updated
Oral methylxanthines for bronchiectasis
Oral non steroid anti-inflammatories for children and adults with bronchiectasis
Oral steroids for bronchiectasis (stable and acute exacerbations)
Oral theophylline for chronic obstructive pulmonary disease
Oral theophylline for stable asthma in adults (protocol stage)
Oral xanthines as maintenance treatment for asthma in children
Oxatomide for stable asthma in adults and children
Oxygen therapy during exercise training in chronic obstructive pulmonary disease
withdrawn
Oxygen therapy for obstructive sleep apnea (protocol stage)
Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease
Oxygen versus air for nebulising beta-agonist bronchodilators in acute asthma (protocol stage)
Palliative oxygen for non-hypoxaemic chronic obstructive pulmonary disease (protocol stage)
Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children
Pet allergen control measures for allergic asthma in children and adults
Phosphodiasterase III inhibitors for chronic asthma (protocol stage)
withdrawn
Phosphodiasterase IV inhibitors for chronic asthma (protocol stage)
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease (protocol stage)
Phosphodiesterase five inhibitors for pulmonary hypertension
Physical training for asthma
Physical training for bronchiectasis
New
Physical training for interstitial lung disease
Updated
Pneumococcal vaccine for asthma
Pneumococcal vaccines for children and adults with bronchiectasis
Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea
Pressure setting and titration strategies for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea (title stage)
withdrawn
Pressure support ventilation following acute ventilatory failure in chronic obstructive pulmonary disease (protocol stage)
Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma
Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease
Pressurised-metered dose inhalers versus other hand-held inhalation devices for the delivery of inhaled corticosteroid therapy in children with non-acute asthma (protocol stage)
Pressurised-metred does inhalers versus hand-held inhalers for the delivery of corticosteroids in adults with asthma (protocol stage)
Primary care based clinics for asthma
Prolonged antibiotics for purulent bronchiectasis in children and adults
Prophylactic antibiotic therapy for chronic bronchitis
Prostacyclin for pulmonary hypertension in adults
Psychological interventions for adults with asthma
Psychological interventions for children with asthma
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease (protocol stage)
Pulmonary rehabilitation for chronic obstructive pulmonary disease
withdrawn
Red sage root for cor pulmonale (protocol stage)
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events (protocol stage)
New
Regular treatment with formoterol for chronic asthma: serious adverse events
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events (title stage)
Regular treatment with formoterol with inhaled corticosteroids versus regular treatment with salmeterol with inhaled corticosteroids for chronic asthma: serious adverse events (title stage)
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events (protocol stage)
Updated
Regular treatment with salmeterol for chronic asthma: serious adverse events
Restriction of oral intake of water for aspiration lung disease in children
School-based education interventions for asthma in children (title stage)
Selenium supplementation for asthma
Self-management education and regular practitioner review for adults with asthma
Self-management education for patients with chronic obstructive pulmonary disease
Short acting beta2-agonists for bronchiectasis
Short acting beta2-agonists for recurrent wheeze in children under two years of age
Short-acting beta2-agonists for stable chronic obstructive pulmonary disease
Short-term ambulatory oxygen for chronic obstructive pulmonary disease
Singing for children and adults with bronchiectasis (title stage)
Smoking cessation for chronic obstructive pulmonary disease
Speleotherapy for asthma
Supervised physical exercise training for chronic obstructive pulmonary disease: long-term efficacy and safety (protocol stage)
Surgery for obstructive sleep apnoea in adults
Surgery versus non-surgical treatment for bronchiectasis
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults
Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults
Tartrazine exclusion for allergic asthma
Telehealthcare for asthma (title stage)
Telehealthcare for chronic obstructive pulmonary disease (title stage)
Tiotropium for stable chronic obstructive pulmonary disease
Triamcinolone versus placebo for chronic asthma in children and adults (protocol stage)
Troleandomycin as an oral corticosteroid sparing agent in stable asthma
Type and intensity of exercise for lower limb endurance training to optimise exercise capacity for people with chronic obstructive pulmonary disease (title stage)
Vaccines for preventing influenza in people with asthma
Vitamin C supplementation for asthma
Water-based exercise training for chronic obstructive pulmonary disease (title stage)
Workplace interventions for treatment of occupational asthma (protocol stage)
Written action plans for asthma in children
Written emotional disclosure for asthma (title stage)
Written individualised management plans for asthma in children and adults